Loading...
The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
BACKGROUND: Chloroquine, a quinolone antimalarial drug, is known to potentially inhibit pH-dependent viral replication of the SARS-CoV‑2 infection. Therefore, chloroquine is considered as a treatment option for coronavirus disease 2019 (COVID-19). Chloroquine is known for prolonging the QT interval,...
Saved in:
| Published in: | Neth Heart J |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Bohn Stafleu van Loghum
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7346846/ https://ncbi.nlm.nih.gov/pubmed/32648153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12471-020-01462-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|